Despite a decrease in utilization of pharmaceuticals among injured workers, sharp price increases continue to drive costs upward.

Pharmacogentic testing has the potential to save money and even lives, but a great deal of skepticism remains.

Baby boomers have higher rates of substance abuse than generations before them, which could complicate workers’ comp claims and further lengthen recovery time.

Employers must ensure that their networks comply with policies governing physician dispensing and compounded drug prescriptions.

As treatments including medical marijuana gain traction in the workers’ comp space, employers need new strategies to manage the risks and contain costs.

Healthcare Solutions CEO Joe Boures answers R&I’s questions on client service, industry consolidation and the best Philly cheesesteaks.

Expert opinion is mixed on whether a new class of painkillers will solve the problems plaguing pain management efforts.

Physicians are not monitoring their patients’ opioid prescriptions closely enough, but PBMs can push guideline adherence.

California lawmakers are being cautioned to proceed carefully before instituting a closed pharmaceutical formulary.

A new report says health care payers last year confronted a “seismic change” in the pharmacy landscape in 2014.

A new study concludes that injured workers are at significantly higher risk for unintentional overdose when prescribed long-acting opioids.

A new study says the focus needs to change from addressing the nonmedical use of painkillers to preventing and treating addiction.

Employers don’t need to be at the mercy of unscrupulous providers or state laws to control their medical costs, advised panelists at a recent webinar.

Workers’ comp payers are worried about poly-substance abuse cases, and the issue of who is liable if a mix of drugs proves lethal.

Industry experts share their thoughts about the challenges and trends facing workers’ comp professionals going forward.

New research reveals workers’ comp claimants receiving urine drug tests when doctors have not prescribed opioid pain medications.

A South Carolina commission suggests that more education for physicians is necessary in order to reduce overprescribing.

Some providers are exploiting loopholes designed to rein in the cost of physician-dispensed drugs.

Researchers from the Workers Compensation Research Institute were surprised by evidence that physicians allowed to dispense medications prescribed unnecessarily strong opioids.

State official says work should begin immediately on the creation of a fee schedule that is fair and based on the real costs of health care in New Hampshire.